SACK1B and non-small cell lung carcinoma: Okabe et al. found that the positive rate of FAM83B expression was 94.7%, the sensitivity was 94.5% and specificity was 85.3% in NSCLC; while the positive rate was only 14.7% in adenocarcinoma.